** CK Life Sciences 0775.HK soars as much as 41.7% to HK$0.68, highest since November 2023
** Stock on course for biggest one-day pct rise since June 2022; fourth biggest pct gainer on HK bourse
** Healthcare and pharma products maker files Original Grant Patent application in Hong Kong and provisional patent application with the U.S. Patent and Trademark Office for its circular mRNA and fusion protein TROP2 cancer vaccines
** Says successful commercialisation of TROP2 cancer vaccine could potentially generate significant economic benefits for co
** Stock up 17.1% YTD
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.